Coherus Oncology CHRS
NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Coherus Oncology (CHRS) EV to FCF (2019 - 2026)

Updated

Coherus Oncology's EV to FCF was 0.31 in Q1 2026, down 4.1% from 0.32 a year earlier.

Analysis

Coherus Oncology (CHRS) EV to FCF (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Coherus Oncology's EV to FCF was -1.67 through Mar 31, 2026; for FY2025, it came in at 0.00.

  • In earlier years, EV to FCF was 0.16 in FY2024.
  • Quarterly EV to FCF has moved between -0.41 (Q2 2025) and 16.48 (Q3 2021) over five years.
  • Per Business Quant data, CHRS's EV to FCF in the three quarters before Q1 2026 was 0.00 (Q4 2025), 0.00 (Q3 2025) and -0.41 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Coherus Oncology 155.59 Mn -480.55 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 0.31
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 -0.41
Mar 31, 2025 0.32
Dec 31, 2024 0.16
Sep 30, 2024 0.13
Jun 30, 2024 0.23
Mar 31, 2024 0.33
Sep 30, 2021 16.48
Jun 30, 2021 7.73
Mar 31, 2021 4.90
Dec 31, 2020 4.89
Sep 30, 2020 6.19
Jun 30, 2020 5.82
Mar 31, 2020 10.02
Dec 31, 2019 41.04
API Access

Coherus Oncology EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=CHRS&period=max&api_key=YOUR_API_KEY